A Study of the Effect of Oats on Post Prandial Glucose Response
A Randomized, Controlled, Cross-over Study of the Effect of Oats on Post Prandial Glucose Response
1 other identifier
interventional
24
1 country
1
Brief Summary
The objectives are to assess the effects of high viscosity vs. medium and low viscosity oat β-glucan on post-prandial glycemic response in healthy adult participants.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Apr 2016
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
January 6, 2016
CompletedFirst Posted
Study publicly available on registry
January 11, 2016
CompletedStudy Start
First participant enrolled
April 1, 2016
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 10, 2016
CompletedStudy Completion
Last participant's last visit for all outcomes
December 10, 2016
CompletedJanuary 23, 2023
April 1, 2021
8 months
January 6, 2016
January 19, 2023
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Blood Glucose
Total area under the curve (iAUC, mmol\*min/L) for glucose
0-200 mins
Secondary Outcomes (4)
Appetite (visual analogue scales)
0-200 mins
Physical Comfort
0-200 mins
Energy/Fatigue
0-200mins
Palatability
at 5 mins
Study Arms (3)
Low Viscous
EXPERIMENTALLow Viscous Beta Glucan Oatmeal
Medium Viscous
EXPERIMENTALMedium Viscous Beta Glucan Oatmeal
High Viscous
EXPERIMENTALHigh Viscous Beta Glucan Oatmeal
Interventions
Eligibility Criteria
You may qualify if:
- Normoglycemic (\<5.6 mmol/L)
- BMI= 18.5-29.9 kg/m²
You may not qualify if:
- A change in medication (dose or type) or medical event requiring hospitalization within the past month.
- Daily tobacco use.
- Eat meals at irregular or unusual times.
- Food allergy, aversion or unwillingness to eat study foods.
- Use of any prescription or non-prescription drug, herbal or nutritional supplement known to affect blood sugar.
- Presence of a gastrointestinal disorder.
- Currently pregnant or lactating.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- University of Manitobalead
- PepsiCo Global R&Dcollaborator
Study Sites (1)
Richardson Centre for Functional Foods and Nutraceuticals, University of Manitoba
Winnipeg, Manitoba, R3T 6C5, Canada
Study Officials
- PRINCIPAL INVESTIGATOR
Peter Jones, PhD
University of Manitoba
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- TRIPLE
- Who Masked
- PARTICIPANT, INVESTIGATOR, OUTCOMES ASSESSOR
- Purpose
- BASIC SCIENCE
- Intervention Model
- CROSSOVER
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
January 6, 2016
First Posted
January 11, 2016
Study Start
April 1, 2016
Primary Completion
December 10, 2016
Study Completion
December 10, 2016
Last Updated
January 23, 2023
Record last verified: 2021-04